Weiss Amir 4
4 · TEVA PHARMACEUTICAL INDUSTRIES LTD · Filed Mar 5, 2026
Insider Transaction Report
Form 4
Weiss Amir
Chief Accounting Officer
Transactions
- Exercise/Conversion
Ordinary Shares
[F1][F2]2026-03-03+5,179→ 10,829 total - Exercise/Conversion
Restricted Share Units
[F2][F3][F1]2026-03-03−5,179→ 5,180 total→ Ordinary Shares (5,179 underlying)
Footnotes (3)
- [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F2]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
- [F3]Restricted share units were granted on March 3, 2023, with 5,179 vested on each of March 3, 2024, March 3, 2025 and March 3, 2026, and 5,180 vesting on March 3, 2027.
Signature
/s/ Dov Bergwerk as attorney-in-fact for Amir Weiss|2026-03-05